{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:57:35Z","timestamp":1790863055740,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/inf.0b013e3180cc2c25","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T08:03:14Z","timestamp":1185264194000},"page":"716-722","source":"Crossref","is-referenced-by-count":73,"title":["Reconsideration of the Use of Meningococcal Polysaccharide Vaccine"],"prefix":"10.1097","volume":"26","author":[{"given":"Dan M.","family":"Granoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","article-title":"Vaccines. 4th ed.","author":"Granoff","year":"2003"},{"key":"R2-11-20210202","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-11-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.53393\/rial.1978.38.37124","article-title":"Avaliacao do efeito protector de vacina polissacaridica antimeningococica do groupo C, em criancas de 6 A 36 meses.","volume":"38","author":"Taunay","year":"1978","journal-title":"Rev Inst Adolfo Lutz"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease.","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/S0264-410X(01)00209-2","article-title":"Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.","volume":"19","author":"Lingappa","year":"2001","journal-title":"Vaccine"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S0950268802007549","article-title":"National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001.","volume":"129","author":"Shigematsu","year":"2002","journal-title":"Epidemiol Infect"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.12968\/hosp.2002.63.5.2017","article-title":"Epidemiology of meningococcal disease.","volume":"63","author":"Cartwright","year":"2002","journal-title":"Hosp Med"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.286.6.694","article-title":"Invasive meningococcal disease in adolescents and young adults.","volume":"286","author":"Harrison","year":"2001","journal-title":"JAMA"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2005.03.031","article-title":"Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.","volume":"23","author":"Granoff","year":"2005","journal-title":"Vaccine"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2004.02.028","article-title":"Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A\/C-diphtheria toxoid conjugate vaccine in infants in Niger.","volume":"22","author":"Chippaux","year":"2004","journal-title":"Vaccine"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial.","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A + C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.","volume":"19","author":"Campagne","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00123-06","article-title":"Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.","volume":"13","author":"Vu","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.inf.0000187027.45918.6a","article-title":"Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.","volume":"24","author":"Collins","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0950268899003787","article-title":"Induction of immunological memory in UK infants by a meningococcal A\/C conjugate vaccine.","volume":"124","author":"Borrow","year":"2000","journal-title":"Epidemiol Infect"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated versus plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/175.1.200","article-title":"Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide\u2014protein conjugate vaccine.","volume":"175","author":"Leach","year":"1997","journal-title":"J Infect Dis"},{"key":"R28-11-20210202","first-page":"245","article-title":"Meningococcal Disease.","author":"Frasch","year":"1995"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway.","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"R31-11-20210202","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a pre-diversified immunoglobulin repertoire.","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.it.2004.11.004","article-title":"Vaccination against encapsulated bacteria in humans: paradoxes.","volume":"26","author":"Weller","year":"2005","journal-title":"Trends Immunol"},{"key":"R33-11-20210202","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/eji.200535446","article-title":"Splenic marginal zone B cells in humans: where do they mutate their Ig receptor?","volume":"35","author":"Weller","year":"2005","journal-title":"Eur J Immunol"},{"key":"R35-11-20210202","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.","volume":"56","author":"Gold","year":"1975","journal-title":"J Clin Invest"},{"key":"R36-11-20210202","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0264-410X(00)00317-0","article-title":"Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.","volume":"19","author":"Borrow","year":"2000","journal-title":"Vaccine"},{"key":"R37-11-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"key":"R38-11-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/CDLI.11.6.1100-1104.2004","article-title":"Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.","volume":"11","author":"Southern","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"R39-11-20210202","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood.","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"},{"key":"R40-11-20210202","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.","volume":"73","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"key":"R41-11-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/322024","article-title":"Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.","volume":"184","author":"Borrow","year":"2001","journal-title":"J Infect Dis"},{"key":"R42-11-20210202","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.283.14.1821","article-title":"Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?","volume":"283","author":"MacDonald","year":"2000","journal-title":"JAMA"},{"key":"R43-11-20210202","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(01)00050-0","article-title":"Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A\/C polysaccharide vaccine and vaccine-naive controls.","volume":"19","author":"Borrow","year":"2001","journal-title":"Vaccine"},{"key":"R44-11-20210202","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen specific memory B cells.","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"R45-11-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s281-001-8166-x","article-title":"Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.","volume":"23","author":"Adderson","year":"2001","journal-title":"Springer Semin Immunopathol"},{"key":"R46-11-20210202","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.172.1.532","article-title":"Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.","volume":"172","author":"Khan","year":"2004","journal-title":"J Immunol"},{"key":"R47-11-20210202","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/IAI.69.4.2378-2382.2001","article-title":"Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.","volume":"69","author":"Richmond","year":"2001","journal-title":"Infect Immun"},{"key":"R48-11-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","article-title":"Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.","volume":"185","author":"Goldblatt","year":"2002","journal-title":"J Infect Dis"},{"key":"R49-11-20210202","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.inf.0000243215.46312.4a","article-title":"Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.","volume":"25","author":"Pichichero","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R50-11-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/317667","article-title":"Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy.","volume":"183","author":"MacLennan","year":"2001","journal-title":"J Infect Dis"},{"key":"R51-11-20210202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","article-title":"Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine.","volume":"23","author":"Granoff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R52-11-20210202","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type B conjugate vaccines following infant immunization.","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"key":"R53-11-20210202","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R54-11-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/inf.1977.9.issue-2.09","article-title":"Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence.","volume":"9","author":"Edwards","year":"1977","journal-title":"Scand J Infect Dis"},{"key":"R55-11-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"R56-11-20210202","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.329.7467.655","article-title":"Trends in Haemophilus influenzae type B infections in adults in England and Wales: surveillance study.","volume":"329","author":"McVernon","year":"2004","journal-title":"BMJ"},{"key":"R57-11-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/S0950268804002122","article-title":"Long-term impact of vaccination on Haemophilus influenzae type B (Hib) carriage in the United Kingdom.","volume":"132","author":"McVernon","year":"2004","journal-title":"Epidemiol Infect"},{"key":"R58-11-20210202","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.inf.0000076386.52719.b3","article-title":"Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.","volume":"22","author":"McVernon","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R59-11-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/505077","article-title":"Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization.","volume":"194","author":"Vu","year":"2006","journal-title":"J Infect Dis"},{"key":"R60-11-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from post-licensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R61-11-20210202","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"R62-11-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"R63-11-20210202","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/344273","article-title":"Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964\u20131998.","volume":"35","author":"Brundage","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R64-11-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.279.6.435","article-title":"Efficacy of meningococcal vaccine and barriers to vaccination.","volume":"279","author":"Rosenstein","year":"1998","journal-title":"JAMA"},{"key":"R65-11-20210202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.1995.03520290035026","article-title":"Serogroup C meningococcal outbreaks in the United States. An emerging threat.","volume":"273","author":"Jackson","year":"1995","journal-title":"JAMA"},{"key":"R66-11-20210202","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.vaccine.2005.12.018","article-title":"Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.","volume":"24","author":"El Bashir","year":"2006","journal-title":"Vaccine"},{"key":"R67-11-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000151035.64356.f8","article-title":"Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine.","volume":"24","author":"Granoff","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R68-11-20210202","first-page":"364","article-title":"Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, October 2005-February 2006.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R69-11-20210202","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomized study.","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"key":"R70-11-20210202","first-page":"617","article-title":"Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand.","volume":"11","author":"Lennon","year":"1992","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3180cc2c25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:47:54Z","timestamp":1737323274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200708000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3180cc2c25","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}